SCHEMBL4772515

SCHEMBL4772515

Cn1cnc2c(=O)n(-c3ccc(F)c(F)c3)c(Cc3ccc(Cl)cc3Cl)nc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.38
F2RL3 Q96RI0 1/20 0.37
TP53 P04637 2/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
BRD9 Q9H8M2 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSP90B1 P14625 1/20 0.36
TSHR P16473 3/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK14 Q16539 1/20 0.35
POLB P06746 2/20 0.35
P2RX7 Q99572 2/20 0.35
ABL1 P00519 1/20 0.35
RIN1 Q13671 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525470 0.93 MAPK1 (0.44) KMT2ATP53HTTBRD9MAPK1
SCHEMBL4520689 0.93 MAOB (0.37) KMT2AF2RL3TP53BRD9MAPK1
SCHEMBL4510103 0.91 KMT2A (0.44) KMT2AF2RL3TP53HTTSMN1; SMN2
SCHEMBL4520099 0.91 F2RL3 (0.40) KMT2AF2RL3TP53HTTSMN1; SMN2
SCHEMBL4519193 0.89 PDE4B (0.39) KMT2AF2RL3BRD9MAPK1NPSR1
SCHEMBL4521143 0.87 MAPK1 (0.44) KMT2ATP53HTTBRD9MAPK1
SCHEMBL4521884 0.87 MAPK1 (0.45) KMT2ATP53HTTSMN1; SMN2MAPK1
SCHEMBL4520494 0.87 MAOB (0.38) KMT2AF2RL3HTTBRD9MAPK1
SCHEMBL4517370 0.86 GRM1 (0.37) BRD9MAPK1NPSR1MAPK14POLB
SCHEMBL4522019 0.86 MAPK14 (0.36) TP53SMN1; SMN2BRD9MAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed